Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate a home-based approach to influenza infection control, using
prepositioned home-based influenza self-test kits, telemedicine services, and rapid delivery
of Xofluza (Baloxavir marboxil) for administration within 48 hours of symptom onset.